A Phase 2 Open-Label Study of AMG 706 to Treat Subjects with Locally Advanced or Metastatic Thyroid Cancer

Mise à jour : Il y a 4 ans
Référence : EUCTR2005-001618-42

Femme et Homme

  • | Pays :
  • -
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

To determine the effect of AMG 706 on the objective response rate (complete response and partial response) in subjects with locally advanced or metastatic thyroid cancer in each of 2 strata: medullary thyroid cancer and differentiated thyroid cancer.


Critère d'inclusion

  • Locally advanced or metastatic thyroid cancer